Literature DB >> 23886644

Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies.

Mary D Le1, Elena Enbom, Peter K Traum, Valentina Medici, Charles H Halsted, Samuel W French.   

Abstract

BACKGROUND: The objective of this study is to assess if there were any changes in liver biopsies after treatment with S-adenosyl-L-methionine(SAMe) in alcoholic liver disease patients.
METHODS: Liver biopsies of 14 patients were randomized for SAMe treatment at week 0 (biopsy #1) and at 24 weeks (biopsy #2). Patients received 1.2g of SAMe or placebo by mouth daily and stopped alcohol intake. Biopsies were semi-quantitatively scored for: steatosis, inflammation, necrosis, fibrosis, apoptosis by TUNEL stain, percent fibrosis per square field, smooth muscle actin stain, Kupffer cells, polymorphonuclear leukocytes, lipogranules, lymphocytes, balloon cell formation, Mallory-Denk bodies, and duct metaplasia.
RESULTS: Comparing treatment arm to placebo arm, no significant difference was found between biopsy #1 and biopsy #2. However, when both study arms were grouped together, there was decrease in smooth muscle actin stain, where the P-value=0.027.
CONCLUSION: Treatment with SAMe did not show a statistically significant difference in the characteristics studied. However, when both the treatment and placebo arm data were grouped together to increase the n and power, there was a decrease in the smooth muscle actin stain, reflecting a decrease in stellate cells activation, likely due to the alcohol abstinence. This study suggests that it may not be beneficial to wait for more definitive treatment, like liver transplant in alcoholic liver disease patients, since the liver tissue remained largely with the same degree of pathology six months out, regardless of treatment.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; Liver biopsies; S-adenosyl-l-methionine; Smooth muscle actin

Mesh:

Substances:

Year:  2013        PMID: 23886644      PMCID: PMC3857393          DOI: 10.1016/j.yexmp.2013.07.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  12 in total

1.  S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial.

Authors:  Valentina Medici; Maria C Virata; Janet M Peerson; Sally P Stabler; Samuel W French; Jesse F Gregory; Anthony Albanese; Christopher L Bowlus; Sridevi Devaraj; Edward A Panacek; John R Richards; Charles H Halsted
Journal:  Alcohol Clin Exp Res       Date:  2011-11       Impact factor: 3.455

2.  The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.

Authors:  N Akpolat; S Yahsi; A Godekmerdan; M Yalniz; K Demirbag
Journal:  Histopathology       Date:  2005-09       Impact factor: 5.087

Review 3.  Pathology of alcoholic liver disease. VA Cooperative Study Group 119.

Authors:  S W French; J Nash; P Shitabata; K Kachi; C Hara; A Chedid; C L Mendenhall
Journal:  Semin Liver Dis       Date:  1993-05       Impact factor: 6.115

4.  Mechanism for prevention of alcohol-induced liver injury by dietary methyl donors.

Authors:  Christine L Powell; Blair U Bradford; Christopher Patrick Craig; Masato Tsuchiya; Takeki Uehara; Thomas M O'Connell; Igor P Pogribny; Stepan Melnyk; Dennis R Koop; Lisa Bleyle; David W Threadgill; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2010-01-29       Impact factor: 4.849

Review 5.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

6.  S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

Authors:  J M Mato; J Cámara; J Fernández de Paz; L Caballería; S Coll; A Caballero; L García-Buey; J Beltrán; V Benita; J Caballería; R Solà; R Moreno-Otero; F Barrao; A Martín-Duce; J A Correa; A Parés; E Barrao; I García-Magaz; J L Puerta; J Moreno; G Boissard; P Ortiz; J Rodés
Journal:  J Hepatol       Date:  1999-06       Impact factor: 25.083

7.  Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats.

Authors:  Zuojiong Gong; Shaonan Yan; Ping Zhang; Yanqing Huang; Luwen Wang
Journal:  Hepatol Int       Date:  2008-07-25       Impact factor: 6.047

8.  S-adenosylmethionine attenuates oxidative liver injury in micropigs fed ethanol with a folate-deficient diet.

Authors:  Jesus A Villanueva; Farah Esfandiari; Mollie E White; Sridevi Devaraj; Samuel W French; Charles H Halsted
Journal:  Alcohol Clin Exp Res       Date:  2007-09-11       Impact factor: 3.455

Review 9.  Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.

Authors:  Vishnudutt Purohit; Manal F Abdelmalek; Shirish Barve; Norlin J Benevenga; Charles H Halsted; Neil Kaplowitz; Kusum K Kharbanda; Qi-Ying Liu; Shelly C Lu; Craig J McClain; Christine Swanson; Samir Zakhari
Journal:  Am J Clin Nutr       Date:  2007-07       Impact factor: 7.045

10.  Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis.

Authors:  Taunia D Lee; Mamatha R Sadda; Michel H Mendler; Teodoro Bottiglieri; Gary Kanel; José M Mato; Shelly C Lu
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455

View more
  4 in total

Review 1.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  How to prevent alcoholic liver disease.

Authors:  S W French
Journal:  Exp Mol Pathol       Date:  2015-03-07       Impact factor: 3.362

Review 4.  Pathogenesis of Alcoholic Liver Disease.

Authors:  Winston Dunn; Vijay H Shah
Journal:  Clin Liver Dis       Date:  2016-03-28       Impact factor: 6.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.